Home
VKTX
VKTX News

Latest Viking Therapeutics Inc. (VKTX) News on July 26, 2024

June PCE inflation print, auto earnings: Morning Brief

Yahoo Finance Video

6 hours ago

June PCE inflation print, auto earnings: Morning Brief

Viking’s new dual GLP-1R/GIPR agonist expected to start Phase III trials soon

Clinical Trials Arena

9 hours ago

Viking’s new dual GLP-1R/GIPR agonist expected to start Phase III trials soon

Eli Lilly loses $120B in value over Viking's GLP-1 progress

Yahoo Finance Video

9 hours ago

Eli Lilly loses $120B in value over Viking's GLP-1 progress

Why Weight Loss Drug Developer Stocks Tumbled on Thursday

Motley Fool

a day ago

Why Weight Loss Drug Developer Stocks Tumbled on Thursday

MT Newswires

a day ago

Top Midday Gainers

MT Newswires

a day ago

Sector Update: Health Care Stocks Mixed in Afternoon Trading

Why Viking’s Weight-Loss Drug News Is Weighing on Eli Lilly, Novo Nordisk Stocks

Investopedia

a day ago

Why Viking’s Weight-Loss Drug News Is Weighing on Eli Lilly, Novo Nordisk Stocks

Why Viking Therapeutics Stock Is Skyrocketing Today

Motley Fool

a day ago

Why Viking Therapeutics Stock Is Skyrocketing Today

MT Newswires

a day ago

Update: Viking Therapeutics Shares Jump After Q2 Loss Widens Less Than Projected

Viking Therapeutics weight-loss drug moves to Phase 3 trial

Yahoo Finance Video

a day ago

Viking Therapeutics weight-loss drug moves to Phase 3 trial

Viking (VKTX) Q2 Earnings Beat, Stock Up on Pipeline Updates

Zacks

a day ago

Viking (VKTX) Q2 Earnings Beat, Stock Up on Pipeline Updates

Viking Therapeutics Unveils Monthly Weight-Loss Shot, And Rocks Eli Lilly, Novo Nordisk

Investor's Business Daily

a day ago

Viking Therapeutics Unveils Monthly Weight-Loss Shot, And Rocks Eli Lilly, Novo Nordisk

MT Newswires

2 days ago

Top Premarket Gainers

Nvidia, Ford, Chipotle, Viking Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today

Benzinga

2 days ago

Nvidia, Ford, Chipotle, Viking Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today

MT Newswires

2 days ago

Viking Therapeutics Q2 Loss Widens; Cash Runway Guidance Issued -- Shares Jump After Hours

Viking Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

PR Newswire

2 days ago

Viking Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

The Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences

Zacks

2 days ago

The Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences

Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?

Zacks

3 days ago

Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?

Missed Out on Eli Lilly? These 2 Healthcare Stocks Have Big Catalysts on the Horizon.

Motley Fool

4 days ago

Missed Out on Eli Lilly? These 2 Healthcare Stocks Have Big Catalysts on the Horizon.

This market expert warns real estate woes may not be limited to commercial — 3 'idiosyncratic' stocks he likes

Moneywise

6 days ago

This market expert warns real estate woes may not be limited to commercial — 3 'idiosyncratic' stocks he likes

3 Monster Stocks in the Making to Buy Right Now

Motley Fool

7 days ago

3 Monster Stocks in the Making to Buy Right Now

Viking Therapeutics, Inc. (VKTX) Gains As Market Dips: What You Should Know

Zacks

7 days ago

Viking Therapeutics, Inc. (VKTX) Gains As Market Dips: What You Should Know

Should Viking (VKTX) Stock be in Your Portfolio Pre-Q2 Earnings?

Zacks

7 days ago

Should Viking (VKTX) Stock be in Your Portfolio Pre-Q2 Earnings?

Is Viking Therapeutics a Millionaire-Maker?

Motley Fool

8 days ago

Is Viking Therapeutics a Millionaire-Maker?

Why the Market Dipped But Viking Therapeutics, Inc. (VKTX) Gained Today

Zacks

8 days ago

Why the Market Dipped But Viking Therapeutics, Inc. (VKTX) Gained Today

Eli Lilly, Novo Nordisk — And Their Rivals — Skid On Roche's Weight-Loss Drug Results

Investor's Business Daily

9 days ago

Eli Lilly, Novo Nordisk — And Their Rivals — Skid On Roche's Weight-Loss Drug Results

Viking Therapeutics to Report Financial Results for Second Quarter 2024 on July 24, 2024

PR Newswire

9 days ago

Viking Therapeutics to Report Financial Results for Second Quarter 2024 on July 24, 2024

Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?

Benzinga

9 days ago

Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?

Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data

Investor's Business Daily

9 days ago

Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data

Is Viking Therapeutics the Best Biotech Stock for You?

Motley Fool

10 days ago

Is Viking Therapeutics the Best Biotech Stock for You?

We're Not Worried About Viking Therapeutics' (NASDAQ:VKTX) Cash Burn

Simply Wall St.

14 days ago

We're Not Worried About Viking Therapeutics' (NASDAQ:VKTX) Cash Burn

Is Viking Therapeutics Stock Running Out of Steam?

Motley Fool

16 days ago

Is Viking Therapeutics Stock Running Out of Steam?

Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics

Motley Fool

17 days ago

Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics

Viking (VKTX) Skyrockets 197% YTD: Is the Stock Worth a Buy?

Zacks

24 days ago

Viking (VKTX) Skyrockets 197% YTD: Is the Stock Worth a Buy?

Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year?

Motley Fool

25 days ago

Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year?

3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics

Motley Fool

a month ago

3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

Motley Fool

a month ago

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

What Makes Viking Therapeutics, Inc. (VKTX) One of the Best Healthcare Stocks to Buy Under $50?

Insider Monkey

a month ago

What Makes Viking Therapeutics, Inc. (VKTX) One of the Best Healthcare Stocks to Buy Under $50?

MT Newswires

a month ago

Morgan Stanley Initiates Viking Therapeutics at Overweight With $105 Price Target

Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks

a month ago

Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know

Better Growth Stock: Archer Aviation or Viking Therapeutics?

Motley Fool

a month ago

Better Growth Stock: Archer Aviation or Viking Therapeutics?

Viking Therapeutics Presents Preclinical Data on Novel Dual Amylin and Calcitonin Receptor Agonists at 84th Scientific Sessions of the American Diabetes Association

PR Newswire

a month ago

Viking Therapeutics Presents Preclinical Data on Novel Dual Amylin and Calcitonin Receptor Agonists at 84th Scientific Sessions of the American Diabetes Association

Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today

Zacks

a month ago

Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today

Here’s Why Viking Therapeutics (VKTX) Stock Skyrocketed in Q1

Insider Monkey

a month ago

Here’s Why Viking Therapeutics (VKTX) Stock Skyrocketed in Q1

The Best Biotech Stock to Invest $1,000 in Right Now

Motley Fool

a month ago

The Best Biotech Stock to Invest $1,000 in Right Now

3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street

Motley Fool

a month ago

3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street

2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80%

Motley Fool

a month ago

2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80%

Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It

Motley Fool

a month ago

Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It

Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug

Motley Fool

a month ago

Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug

Viking Therapeutics, Inc. (VKTX) Stock Declines While Market Improves: Some Information for Investors

Zacks

a month ago

Viking Therapeutics, Inc. (VKTX) Stock Declines While Market Improves: Some Information for Investors

Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?

Zacks

a month ago

Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?

Here’s Why Viking Therapeutics (VKTX) Shares Rose in Q1

Insider Monkey

2 months ago

Here’s Why Viking Therapeutics (VKTX) Shares Rose in Q1

Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals

Motley Fool

2 months ago

Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals

This High-Flying Stock Just Announced More Good News: Time to Buy?

Motley Fool

2 months ago

This High-Flying Stock Just Announced More Good News: Time to Buy?

Viking Therapeutics, Inc. (VKTX) Advances While Market Declines: Some Information for Investors

Zacks

2 months ago

Viking Therapeutics, Inc. (VKTX) Advances While Market Declines: Some Information for Investors

Viking Therapeutics (VKTX) Shares Rose in Q1

Insider Monkey

2 months ago

Viking Therapeutics (VKTX) Shares Rose in Q1

Is Viking Therapeutics Stock a Buy on the Dip?

Motley Fool

2 months ago

Is Viking Therapeutics Stock a Buy on the Dip?

Viking (VKTX) Falls 10% Despite Upbeat NASH Study Results

Zacks

2 months ago

Viking (VKTX) Falls 10% Despite Upbeat NASH Study Results

Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug

Investor's Business Daily

2 months ago

Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug

Stocks retreat on weak JOLTS data, HPE, CrowdStrike earnings on tap: Yahoo Finance

Yahoo Finance Video

2 months ago

Stocks retreat on weak JOLTS data, HPE, CrowdStrike earnings on tap: Yahoo Finance

MT Newswires

2 months ago

Viking Therapeutics Reports 'Positive' 52-Week Results for NASH Drug; Shares Rise Pre-Bell

Viking says biopsy data confirm MASH drug’s benefit

BioPharma Dive

2 months ago

Viking says biopsy data confirm MASH drug’s benefit

Investing.com

2 months ago

Midday movers: Exxon, Gitlab fall; Old Dominion Freight, Saia rise

Viking Therapeutics Announces Positive 52-Week Histologic Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)

PR Newswire

2 months ago

Viking Therapeutics Announces Positive 52-Week Histologic Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)

1 Disruptive Biotech Stock to Buy Now, and 1 to Consider

Motley Fool

2 months ago

1 Disruptive Biotech Stock to Buy Now, and 1 to Consider

The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.

Motley Fool

2 months ago

The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.

Here's Why Viking Therapeutics, Inc. (VKTX) Gained But Lagged the Market Today

Zacks

2 months ago

Here's Why Viking Therapeutics, Inc. (VKTX) Gained But Lagged the Market Today

Viking Therapeutics to Participate at Upcoming Investor Conferences

PR Newswire

2 months ago

Viking Therapeutics to Participate at Upcoming Investor Conferences

Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?

Zacks

2 months ago

Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?

This Biotech Stock is a “Strong Buy” According to Raymond James

Insider Monkey

2 months ago

This Biotech Stock is a “Strong Buy” According to Raymond James

If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today

Motley Fool

2 months ago

If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today

Where Will Viking Therapeutics Be in 5 Years?

Motley Fool

2 months ago

Where Will Viking Therapeutics Be in 5 Years?

2 Stocks That Could 10x by 2035

Motley Fool

2 months ago

2 Stocks That Could 10x by 2035

Is It Too Late to Buy Viking Therapeutics Stock?

Motley Fool

2 months ago

Is It Too Late to Buy Viking Therapeutics Stock?

Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo

Bloomberg

2 months ago

Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo

The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen

Zacks

2 months ago

The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen

3 Monster Stocks in the Making You Can Buy Right Now

Motley Fool

2 months ago

3 Monster Stocks in the Making You Can Buy Right Now

4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly

Zacks

2 months ago

4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly

Is Viking Therapeutics Stock a Buy?

Motley Fool

2 months ago

Is Viking Therapeutics Stock a Buy?

MT Newswires

2 months ago

Raymond James Upgrades Viking Therapeutics to Strong Buy From Outperform

Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?

Zacks

2 months ago

Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?

How Viking Therapeutics Stock Could 30x

Motley Fool

2 months ago

How Viking Therapeutics Stock Could 30x

Is Viking Therapeutics the Best Biotech Stock for You?

Motley Fool

2 months ago

Is Viking Therapeutics the Best Biotech Stock for You?

Viking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 72% of the company

Simply Wall St.

3 months ago

Viking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 72% of the company

MT Newswires

3 months ago

Viking Therapeutics Insider Sold Shares Worth $4,986,008, According to a Recent SEC Filing

MT Newswires

3 months ago

Viking Therapeutics Insider Sold Shares Worth $22,136,474, According to a Recent SEC Filing

Is Viking Therapeutics Incredibly Undervalued?

Motley Fool

3 months ago

Is Viking Therapeutics Incredibly Undervalued?

Can This High-Flying Stock 10x in 10 Years?

Motley Fool

3 months ago

Can This High-Flying Stock 10x in 10 Years?

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript

3 Millionaire-Maker Biotech Stocks

Motley Fool

3 months ago

3 Millionaire-Maker Biotech Stocks

MT Newswires

3 months ago

Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Viking Therapeutics Inc Earnings Call

GuruFocus.com

3 months ago

Viking Therapeutics Inc (VKTX) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...

GuruFocus.com

3 months ago

Viking Therapeutics Reports First Quarter 2024 Results: Aligns with Analyst Projections

MT Newswires

3 months ago

Viking Therapeutics Q1 Loss Widens; Shares Fall After Hours

Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

PR Newswire

3 months ago

Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Motley Fool

3 months ago

Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Zacks

3 months ago

Brian Big Idea On Technical Analysis

Better Buy: Pfizer vs. Viking Therapeutics

Motley Fool

3 months ago

Better Buy: Pfizer vs. Viking Therapeutics

Viking Therapeutics, Inc. (VKTX) Suffers a Larger Drop Than the General Market: Key Insights

Zacks

3 months ago

Viking Therapeutics, Inc. (VKTX) Suffers a Larger Drop Than the General Market: Key Insights

Share on Social Networks: